CRISPR/Cas9-Mediated in vivo Genetic Correction in a Mouse Model of Hemophilia A
Hemophilia A (HA), a common bleeding disorder caused by a deficiency of coagulation factor VIII (FVIII), has long been considered an attractive target for gene therapy studies. However, full-length F8 cDNA cannot be packaged efficiently by adeno-associated virus (AAV) vectors. As the second most pre...
Main Authors: | Sanchuan Luo, Zhongxiang Li, Xin Dai, Rui Zhang, Zhibing Liang, Wenzhou Li, Ming Zeng, Jinfeng Su, Jun Wang, Xia Liang, Yong Wu, Desheng Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.672564/full |
Similar Items
-
Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
by: Yan Feng, et al.
Published: (2016-08-01) -
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
by: Yu Zhang, et al.
Published: (2021-09-01) -
Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
by: Hao Li, et al.
Published: (2018-09-01) -
Editing Citrus Genome via SaCas9/sgRNA System
by: Hongge Jia, et al.
Published: (2017-12-01) -
Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons
by: Yuxi Chen, et al.
Published: (2020-09-01)